These findings have significant implications regarding our understanding of the pathogenesis of SCLC multidrug resistance and highlights the importance of investigating the complicated circRNA-miRNA regulatory gene network as well as TGF-β signalling in SCLC progression and treatment efficacy. This evidence concerns the gene TGFB1 and small cell lung carcinoma.